| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.28B | 896.69M | 708.78M | 536.50M | 908.81M |
| Gross Profit | 87.05M | 76.58M | 71.67M | 24.24M | 61.33M |
| EBITDA | 28.43M | 26.75M | 23.33M | -14.59M | 24.06M |
| Net Income | 9.42M | 10.69M | 11.56M | -18.16M | 11.54M |
Balance Sheet | |||||
| Total Assets | 633.14M | 580.86M | 582.41M | 321.80M | 423.89M |
| Cash, Cash Equivalents and Short-Term Investments | 50.11M | 68.01M | 82.37M | 32.28M | 83.76M |
| Total Debt | 133.08M | 166.16M | 140.29M | 70.20M | 93.29M |
| Total Liabilities | 496.46M | 453.85M | 465.86M | 217.06M | 297.96M |
| Stockholders Equity | 136.68M | 127.01M | 116.55M | 104.74M | 125.94M |
Cash Flow | |||||
| Free Cash Flow | 38.63M | -29.68M | -10.99M | -9.16M | 74.97M |
| Operating Cash Flow | 40.39M | -28.57M | -10.62M | -9.16M | 80.27M |
| Investing Cash Flow | 13.52M | 717.00K | -19.79M | 7.34M | -1.47M |
| Financing Cash Flow | -46.80M | 13.86M | 60.16M | -29.47M | -76.85M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | HK$36.00M | -0.50 | -32.77% | ― | -1.68% | -417.79% | |
56 Neutral | HK$59.00M | 7.17 | -8.98% | ― | 8.51% | -217.24% | |
55 Neutral | HK$60.78M | 6.49 | 6.32% | ― | 46.37% | -22.94% | |
46 Neutral | HK$36.00M | -0.69 | -114.92% | ― | -9.20% | 32.32% | |
40 Underperform | HK$52.05M | -4.72 | 3.09% | ― | -7.34% | ― | |
38 Underperform | HK$17.35M | -0.35 | 9.17% | ― | ― | ― |